67% of drug sponsors indicate that they have limited visibility into CDMO data and process management according to this excellent report from Accenture.  Skyland Analytics very much concurs with these findings based in this report, and supporting external manufacturing within the industry is one of the main drivers why we developed our cloud-based PIMS platform.

Download the Full Article